Evidence map›Paper›PMID 12414948›Full record

ArticleJournal of virology2002

Replication advantage and host factor-independent phenotypes attributable to a common naturally occurring capsid mutation (I97L) in human hepatitis B virus.

Fat-Moon Suk, Min-Hui Lin, Margaret Newman, Shann Pan, Sheng-Hsuan Chen, Jean-Dean Liu, Chiaho Shih

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Fat-Moon SukCenter for Tropical Diseases and Sealy Center for Vaccine Development, Department of Pathology, University of Texas Medical Branch, Galveston, Texas 77555-0609, USA.
Min-Hui Lin
Margaret Newman
Shann Pan
Sheng-Hsuan Chen
Jean-Dean Liu
Chiaho Shih
The University of Texas Medical Branch at Galveston · USTaipei Medical University Hospital · TW

Funding

PATHOGENESIS, CHRONICITY, AND MUTATIONS OF HEPATITIS BR01CA070336 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SHIH, CHIAHO · 1997 to 2004
$1.6M
'IMMATURE SECRETION'VARIANTS OF HUMAN HEPATITIS B VIRUSR01CA084217 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI SHIH, CHIAHO · 2000 to 2004
$1.1M
NCI NIH HHS CA84217NCI NIH HHS R01 CA070336NCI NIH HHS R01 CA084217NCI NIH HHS R01 CA 70336
6 · The paper itself

Abstract

Mutations of human hepatitis B virus (HBV) occur frequently within the capsid (core) protein in natural infections. The most frequent mutation of the core protein in HBV from Southeast Asia occurs at amino acid 97, changing an isoleucine (I) to a leucine (L). In our systematic study of virus-host interactions, we have examined the replication efficiency of a site-directed mutant, I97L, and its parental wild-type HBV in several different hepatoma cell lines. Interestingly, we found that this capsid variant replicated in human Huh7 hepatoma cells approximately 4.8-fold better than its parental wild-type HBV. A similar phenomenon was observed in another hepatoma cell line, J3. In addition, the level of encapsidated RNA pregenome in mutant I97L was about 5.7-fold higher than that of the wild-type HBV in Huh7 cells. Unlike Huh7 cells, no significant difference in viral DNA replication between the same I97L mutant and its parental wild-type HBV was observed in HepG2, a human hepatoblastoma cell line. This finding of a profound replication advantage for mutant I97L in Huh7 and J3 cells but not in HepG2 cells may have important implications for the emergence of this mutant in chronic HBV carriers. We speculate here that the mutation confers a host factor-independent growth advantage for the survival of HBV variants in gradually dedifferentiating hepatocytes and thus helps prolong viral persistence.

Indexed as

Amino Acid SubstitutionCapsid ProteinsCarrier StateCell LineDNA, ViralEvolution, MolecularHepatitis B, ChronicHepatitis B virusHumansMutationPhenotypeRNA, ViralVirus ReplicationCapsid ProteinsDNA, ViralRNA, Viral

Identifiers

PMID12414948
PMCPMC136898
OpenAlexW2133716844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.